A cuproptosis nanocapsule for cancer radiotherapy

You Liao,Dongmei Wang,Chenglu Gu,Xue Wang,Shuang Zhu,Ziye Zheng,Fuquan Zhang,Junfang Yan,Zhanjun Gu

DOI: https://doi.org/10.1038/s41565-024-01784-1

IF: 38.3

2024-09-20

Nature Nanotechnology

Abstract:Residual tumours that persist after radiotherapy often develop acquired radiation resistance, increasing the risk of recurrence and metastasis while providing obstacles to re-irradiation. Using samples from patients and experimental mice, we discovered that FDX1 and LIAS, key regulators of cuproptosis, were up-regulated in residual tumours following radiotherapy, conferring the increased sensitivity to cuproptosis. Therefore, we proposed a novel radiosensitization strategy focused on cuproptosis, using a copper-containing nanocapsule-like polyoxometalate as a paradigm. In an initial demonstration, we showed that the nanocapsule released copper ions in a controlled manner upon exposure to ionizing radiation. Furthermore, radiation-triggered cuproptosis overcame acquired radiation resistance even at clinically relevant radiation doses and activated a robust abscopal effect, with a 40% cure rate in both radioresistant and re-irradiation tumour models. Collectively, targeting cuproptosis is a compelling strategy for addressing acquired radiation resistance, optimizing the local antitumour effects of radiotherapy while simultaneously activating systemic antitumour immunity.

materials science, multidisciplinary,nanoscience & nanotechnology